Specialist
Former VP at Experity Inc
Agenda
- Major trends and developments within the urgent care software and outpatient EMR (electronic medical record) and HER (electronic health record) space
- Core end market competitive landscape, including vendors such as NextGen Healthcare (NASDAQ: NXGN), Experity, eClinicalWorks, Greenway Health and other players
- 2-3-year market growth and performance forecast, highlighting potentially attractive ancillary offerings such as RCM (revenue cycle management)
- Potential platform add-on adjacencies for value proposition and margin expansion
- Threats from increasing consolidation trends of large health systems
- Interoperability efforts and H2 2022 outlook
Questions
1.
What are some major trends and developments you’ve been following in the urgent care software and broader outpatient EMR [electronic medical record] market over the past year or so?
2.
Could you discuss the increasing trend of consumerisation in healthcare and how this is impacting patient care decisions, providers and the tech solutions they partner with?
3.
You mentioned primary care being a signal for what’s happening in the broader industry. What are your thoughts on the increasing partnerships between retailers and primary care physicians and how does this tie into our discussion on consumerisation?
4.
What appetite are you seeing in ambulatory and urgent care demographics to take on shared risk capitation payment models? How quickly is value-based adoption moving in outpatient settings?
5.
How high are some of the migration costs to adapt EMR solutions to process value-based payments?
6.
What ancillary offerings – considering RCM [revenue cycle management], patient engagement, population health and others – do you see as most attractive for ambulatory EMR vendors to build out to create a more holistic and entrenched solution in the marketplace?
7.
Where do you see urgent care and ASC [ambulatory surgical centre] workflows trending over the near-to-mid-term? What new clinical needs might arise for players to create customised, targeted solutions to provide value for customers?
8.
How high are the rip and replace costs with ASCs and urgent care conglomerates to move between vendors? How sticky have some of these contracts been historically?
9.
Are we seeing any top-line pressure on contract renewals either from increased scale of some of the customer conglomerates or from competitive saturation? How tangible are these risks?
10.
What’s your updated perspective on some of the competitive dynamics with larger EMR platforms – such as Epic and Cerner – as they extend their reach into the outpatient space, either via health system consolidation or augmenting their own solutions’ capabilities?
11.
How do you think consolidation dynamics will unfold? Could you predict who might be likely aggregators or take-out targets?
12.
Would you like to highlight anything else around urgent care EMR vendors or mention anything that might be underappreciated about the space?
